MedPath

Comparison of the effect of vitamin B6 and propranolol on Prevention of relapse of migraine headaches in children aged 7-17 years old referring to the pediatric clinic of Amirkabir Arak Hospital

Phase 2
Recruiting
Conditions
migrain.
Migraine
Registration Number
IRCT20191104045328N2
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
62
Inclusion Criteria

Children with migraine headaches at the age of 17-17 years who are allowed to study by their parents.

Exclusion Criteria

Propranolol contraindications, such as difficulty breathing, or wheezing, palms and feet cold, heart rate below 60 per minute, asthma or emphyzema, congestive heart failure, diabetes, hyperthyroidism, depression
Kidney or liver failure
Allergy to Vitamin B 6

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of Migraine Headache Attacks. Timepoint: Measured weekly by the patient himself at baseline and three months after taking the medication. Method of measurement: the watch.;The number of migraine headaches a week. Timepoint: Measured weekly by the patient himself at baseline and three months after taking the medication. Method of measurement: numbers.;The severity of headache disability. Timepoint: Measured weekly by the patient himself at baseline and three months after taking the medication. Method of measurement: with Pediatric Migraine Disability Assessment Score questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath